Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kajaste-Rudnitski

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Methods & Clinical Development|December 9, 2020
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced <i>Ex Vivo</i> and <i>In Vivo</i> Genetic EngineeringMonica Soldi, Lucia Sergi Sergi, Giulia Unali, et al.
The Journal of Experimental Medicine|July 2, 2024
A novel STING variant triggers endothelial toxicity and SAVI diseaseErika Valeri, Sara Breggion, Federica Barzaghi, et al.
Cell Stem Cell|November 13, 2018
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem CellsCarolina Petrillo, Lucy G Thorne, Giulia Unali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Science Translational Medicine|May 31, 2023
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disordersMariasilvia Colantuoni, Raisa Jofra Hernandez, Emanuela Pettinato, et al.
Nature Genetics|April 20, 2005
A variant in the CD209 promoter is associated with severity of dengue diseaseAnavaj Sakuntabhai, Chairat Turbpaiboon, Isabelle Casadémont, et al.
The EMBO Journal|March 27, 2023
Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunityGiulia Unali, Giovanni Crivicich, Isabel Pagani, et al.
Nature Communications|April 18, 2025
AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brainHelena Costa-Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Cancer Cell|October 20, 2023
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastasesThomas Kerzel, Giovanna Giacca, Stefano Beretta, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|December 9, 2020
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced <i>Ex Vivo</i> and <i>In Vivo</i> Genetic EngineeringMonica Soldi, Lucia Sergi Sergi, Giulia Unali, et al.
The Journal of Experimental Medicine|July 2, 2024
A novel STING variant triggers endothelial toxicity and SAVI diseaseErika Valeri, Sara Breggion, Federica Barzaghi, et al.
Cell Stem Cell|November 13, 2018
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem CellsCarolina Petrillo, Lucy G Thorne, Giulia Unali, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsErika Valeri, Giulia Unali, Francesco Piras, et al.
Science Translational Medicine|May 31, 2023
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disordersMariasilvia Colantuoni, Raisa Jofra Hernandez, Emanuela Pettinato, et al.
Nature Genetics|April 20, 2005
A variant in the CD209 promoter is associated with severity of dengue diseaseAnavaj Sakuntabhai, Chairat Turbpaiboon, Isabelle Casadémont, et al.
The EMBO Journal|March 27, 2023
Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunityGiulia Unali, Giovanni Crivicich, Isabel Pagani, et al.
Nature Communications|April 18, 2025
AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brainHelena Costa-Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Cancer Cell|October 20, 2023
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastasesThomas Kerzel, Giovanna Giacca, Stefano Beretta, et al.
Pageof 5